Market Tracker

08/29 5:16pm ET

Immunomedics Inc (NASDAQ:IMMU)

2.71
Delayed Data
As of 4:00pm ET
 -0.01 / -0.37%
Today’s Change
1.50
Today|||52-Week Range
5.44
-11.73%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close2.72
Today’s open2.77
Day’s range2.65 - 2.77
Volume548,027
Average volume (3 months)2,051,365
Market cap$260.8M
Dividend yield--
Data as of 4:00pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+23.39%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+1.45+17.58%
OXFDOxford Immunotec Glo...-0.07-0.67%
TRIBTrinity Biotech PLC+0.48+3.68%
QTNTQuotient Ltd+0.12+2.00%
Data as of 4:00pm ET, 08/29/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts